Weight loss | |||||||
ข่าว | |||||||
Weight-loss jab can cut heart attack and stroke risk in obese adults, firm says - The Guardian The weight-loss jab Wegovy can reduce the risk of major cardiovascular events by 20% in people who are overweight or obese, the company behind the ...
| |||||||
Slimmed-down Jonah Hill steps out amid abuse allegations Hill, 39, flashed a big smile for photographers while showing off his weight loss in a pair of brown slacks and a tucked-in blue T-shirt, ...
| |||||||
Weight-Loss Bonanza Drives Novo Nordisk, Eli Lilly Into Record-High Breakouts Novo Nordisk stock surged Tuesday after the pharmaceutical company said its weight-loss drug reduced the risk of cardiovascular events.
| |||||||
Ethan Suplee Shows 200-Pound Weight Loss in Before & After Photo - Men's Health Actor Ethan Suplee reflected on his body transformation and 200 pound weight loss in a recent "before and after" photo on Instagram.
| |||||||
Hims & Hers plans to launch weight loss business by year-end - Fierce Healthcare Hims & Hers plans to launch weight loss business by year-end as revenue growth streak continues in Q2. By Heather Landi Aug 8, 2023 07:45am.
| |||||||
Weight loss drug Wegovy cuts risk of serious heart problems, company says | The Hill Wegovy is a diabetes medication that was approved for weight loss in 2021, but its popularity exploded when videos of celebrities and influencers ...
| |||||||
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says Popular weight-loss injectable Wegovy reduced cardiovascular death, heart attack, and stroke by 20% in a five-year trial, its manufacturer ...
| |||||||
Weight Loss Drug Wegovy May Help Prevent Heart Attacks - WebMD Study results show semaglutide for weight loss (Wegovy) cut problems in the heart and blood vessels in a 17000-person trial, which should reframe ...
| |||||||
ดูผลการค้นหาเพิ่มเติม | แก้ไขการแจ้งเตือนนี้ |
คุณได้รับอีเมลนี้เพราะคุณได้สมัครรับข้อมูล Google Alerts |
รับการแจ้งเตือนนี้เป็นฟีด RSS |
ส่งข้อเสนอแนะ |
0 ความคิดเห็น:
Post a Comment